Process development and scale-up of recombinant protein vaccines

M11

Course Goals 

Process development and scale-up of recombinant protein vaccines.

Timeline 

Application Deadline:
1 June 2021

Course Dates:
11-12 October 2021 (2 days)

Organiser

Fraunhofer IME,
Aachen Germany

Participant Nr.: max. 15

Contact

Johannes Buyel
johannes.buyel@ime.fraunhofer.de

For questions on the application process: transvacinfo@euvaccine.eu

Course content

A list of the course contents is given on the General strategies in process development for recombinant protein production and purification in different host systems with a special focus on state of the art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification. Typical processes will be discussed using real-life equipment and examples.

Learning Outcomes

Comprehensive insight into the possibilities to conduct and improve process development and scale-up of biomanufacturing processes.

Who should apply

Scientists involved or interested in vaccine R&D and manufacturing projects.

Minimal requirements

Basic understanding of recombinant DNA technology, protein chemistry and typical process unit operations.

Accommodation

Accommodation will be provided. Travel Costs are not included.

Comments

* Due to COVID19 related delays call and training modules' schedule may be subject to change.

Weblink

NA

How to apply>>

Kindly note that not all courses are open for application submission, check open calls to know which for which courses you can apply for at the moment.


Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter